Movement Alert|Astera Labs, Inc. Falls 3.61% in Pre-Market Trading, Semiconductor Sector Under Broad Pressure Ahead of Earnings Despite Morgan Stanley Upgrade

Market Focus
Aug 03

On August 3, Astera Labs, Inc. declined 3.61% in pre-market trading, trading at 299.41 USD/share, with turnover of approximately $8.06 million.

On the news front, despite Morgan Stanley raising its price target on Astera Labs from $240 to $335 while maintaining an Overweight rating, the broader semiconductor sector remained under selling pressure, triggering profit-taking ahead of the company's Q2 earnings report scheduled for August 4 after market close. Market consensus expects EPS of $0.42 for the quarter, representing a 56.82% year-over-year increase, with revenue expected at $360.24 million, up 87.7% from the prior year.

Sector-wide weakness weighed on sentiment, with Micron Technology declining 3.52%, Intel down 1.55%, Advanced Micro Devices falling 1.18%, NVIDIA down 0.47%, and Broadcom sliding 0.44%. As a high-beta connectivity play that had surged over 13% just days earlier on AI server design wins and analyst upgrades, Astera Labs faced amplified profit-taking pressure as investors de-risked positions ahead of the earnings release.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10